Happy Father’s Day! In this week’s Innovation Partners BioBlog, we look at how the changing world of drug prices and health care laws impact pricing. U.S. drug prices fell but may rise sharply depending on future marketplace events. New markets are open now for Paxman’s scalp cooling product, and Express Script signed an agreement that ...

Our focus this week is on the pharmaceutical industry with reports from the ASCO conference shaking up stocks, improving the outlook for some while downgrading others. Many companies are announcing results, cuts, and progress with key oncology drugs this week. Check out the Innovation Partners BioBlog for the latest news. AstraZeneca hails progress with key ...

Drug costs are in the spotlight this week from many quarters. First, drugmakers called out by the Trump Administration for blocking generics are also included in a Kaiser Health study that found that they increased prices by double digits since 2012. The so-called ‘right to try’ bill passed the House and awaits President Trump’s signature, ...

Health insurance is in the news this week as insurers file their 2019 rate requests for Affordable Care Act Exchanges. The bad news: rates appear to be going up across many companies and states. The good news: The ACA appears to have helped more young women receive an earlier cancer diagnosis thanks to extended coverage ...

Major news this week as President Trump launches “American Patients First” to bring down healthcare costs. California advanced a bill to socialize healthcare prices, while Oregon looks to reinstate its own state-based insurance exchange as ACA fees and other issue force them to seek alternatives. This and more in this week’s Innovation Partners BioBlog. California ...

A $1.5 million drug? Yes, according to experts. The high cost of drugs is in the news this week with gene therapy for hemophilia expected to cost over $1 million, President Trump making a speech about drug prices, and indication-based pricing all making the headlines. Read on for more from this week’s Innovation Partners BioBlog. ...

This week’s Innovation Partners BioBlog examines two major themes: the cost of cancer treatment, the Cigna-Express Scripts merger plans, and other top stories in healthcare. Among the topics examined in the cancer treatment category are the costs of genetics-based medicines, which are among the most promising yet expensive treatments available, as well as the closure ...

This week in healthcare news, we look at a new, futuristic skin implant that changes color to mimic a skin mole if it detects rising calcium levels, a potential sign of cancer. Addressing the opioid crisis is again in the news, as is the rising cost of prescription drugs. And lastly, Cigna faces litigation that ...

The FDA is finalizing guidance to accelerate the development of reliable sequencing-based tests. New research shows that immunotherapy, when used in conjunction with chemotherapy, helps lung cancer patients live longer, and the Trump Administration is taking steps to ease ACA essential health benefit requirements. This and more in this week’s Innovation Partners BioBlog. FDA finalizes ...

This week’s BioBlog looks at several interesting developments in the use of technology in the healthcare field. Three companies are looking to use a blockchain-based application to secure and encrypt provider data. Researchers have found over 850 genetic alterations may be the reason why cancer “runs in families”. CVS targets chronic kidney disease with innovative ...